Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.

scientific article published on 13 June 2013

Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2105/AJPH.2013.301211
P932PMC publication ID4007868
P698PubMed publication ID23763404

P2093author name stringR Monina Klevens
Reena Mahajan
Scott D Holmberg
Stephen J Liu
P2860cites workHCV screening practices and prevalence in an MCO, 2000-2007.Q45112392
Identification of Patients with Hepatitis C Virus Infection in New Haven County Primary Care PracticesQ45724552
Evaluation of acute hepatitis C infection surveillance --- United States, 2008Q46264352
GRADE guidelines: 2. Framing the question and deciding on important outcomes.Q54771670
GRADE guidelines 6. Rating the quality of evidence—imprecisionQ57269328
Estimating future hepatitis C morbidity, mortality, and costs in the United StatesQ73073538
The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997Q78447515
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and PreventionQ28286743
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tablesQ29547885
GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)Q29619791
GRADE guidelines: a new series of articles in the Journal of Clinical EpidemiologyQ29619792
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Population-based surveillance for hepatitis C virus, United States, 2006-2007Q33644558
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settingsQ33834958
The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United StatesQ33892586
Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.Q34009271
Is sexual contact a major mode of hepatitis C virus transmission?Q34126319
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.Q34294185
Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.Q34344995
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008Q36100389
Cost-effectiveness and population outcomes of general population screening for hepatitis C.Q36115516
GRADE guidelines: 9. Rating up the quality of evidenceQ37908614
GRADE guidelines: 8. Rating the quality of evidence--indirectnessQ37908616
GRADE guidelines: 5. Rating the quality of evidence--publication biasQ37908618
GRADE guidelines: 7. Rating the quality of evidence--inconsistencyQ37908778
Public health impact of antiviral therapy for hepatitis C in the United StatesQ39939298
Management of hepatitis C patients by primary care physicians in the USA: results of a national surveyQ43034294
Economic model of a birth cohort screening program for hepatitis C virusQ43047944
Identification and management of hepatitis C patients in primary care clinicsQ43049186
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalenceQ43419544
The association between knowledge of hepatitis C virus status and risk behaviors in injection drug usersQ44163628
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.Q44979610
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectUnited States of AmericaQ30
P304page(s)1445-1449
P577publication date2013-06-13
P1433published inAmerican Journal of Public HealthQ4744266
P1476titleIndications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.
P478volume103